Cannabis Terpenes When You Inhale Them: One Controlled Human Trial, a Large Preclinical Literature, and a Dose Gap Nobody Mentions
Inhaled cannabis terpenes have exactly one controlled human trial behind them, and it found that 15 mg of vaporized d-limonene selectively reduced THC-induced anxiety and paranoia while producing no effect at all when given on its own. Every other…
Which Cannabis Terpene Claims Hold Up, and Which Ones Do Not
Do cannabis terpenes do anything, or are the charts on dispensary menus decoration? One controlled human trial supports d-limonene reducing THC-induced anxiety when the two are inhaled together, while limonene alone was indistinguishable from placebo.…
Exploring Minor Cannabinoids and Terpenes in Cannabis Therapy
Minor cannabinoids and terpenes play a crucial role in the entourage effect by physically binding to cannabinoid receptors. This interaction may enhance therapeutic outcomes beyond isolated compounds. Understanding minor cannabinoids and terpenes helps…
Prenylated Apigenin Derivatives from Cannabis sativa L.: Isolation, Biosynthesis, and Anti …
Prenylated apigenin cannabis research reveals novel bioactive compounds from Cannabis sativa. These derivatives represent a unique class of flavonoids with potential therapeutic value. Understanding their biosynthesis may expand cannabis-based treatment…
How Minor Cannabinoids Like THCV and CBDV Influence the Entourage Effect
Minor cannabinoids clinical relevance is gaining attention as THCV and CBDV appear in more products. Understanding their role in the entourage effect is crucial for clinical guidance. This article reviews current evidence and practical advice for…
Nose-to-Brain Delivery System for Incorporating Monoterpenes with Anti-Depressant Potential.
Monoterpenes antidepressant potential is gaining attention for their role in mood regulation. This review highlights nose-to-brain delivery systems enhancing their therapeutic effects. Understanding these mechanisms may support new approaches to…
Cannabis Extracts Effective for Seniors’ Chronic Pain – NORML
Cannabis extracts chronic pain seniors relief shows promising results in recent studies. Plant-derived cannabis extracts outperform synthetic dronabinol in elderly patients. This highlights the potential of full-spectrum cannabis for managing chronic…
In the Mix: 3 More Articles — March 17, 2026
This article reviews cannabinoid pharmacology clinical funding and its impact on cannabis medicine. It highlights policy trends in psychedelic therapy funding for low-income populations. The discussion addresses legal disparities affecting cannabis…
AM News Update: March 17, 2026 – Cannabis Clinical Trials & Mental Health
This AM News Update covers cannabis clinical trials mental health research from March 17, 2026. It highlights recent studies on cannabis efficacy and safety for mental disorders. The update emphasizes the need for rigorous dose-finding studies and…
Boulder and CBD: Understanding Full-Spectrum Benefits
Full-spectrum CBD benefits are key to understanding the entourage effect in cannabis medicine. Patients often experience better relief with full-spectrum formulations than with CBD isolate alone. This synergy of cannabinoids and terpenes offers enhanced…